These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17253538)

  • 1. Risperidone for autism spectrum disorder.
    Jesner OS; Aref-Adib M; Coren E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005040. PubMed ID: 17253538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibitors for autistic spectrum disorders.
    Ure A; Cox GR; Haslam R; Williams K
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013851. PubMed ID: 37267443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole for autism spectrum disorders (ASD).
    Hirsch LE; Pringsheim T
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009043. PubMed ID: 27344135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone alone or in combination for acute mania.
    Rendell JM; Gijsman HJ; Bauer MS; Goodwin GM; Geddes GR
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004043. PubMed ID: 16437472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole for autism spectrum disorders (ASD).
    Ching H; Pringsheim T
    Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone versus typical antipsychotic medication for schizophrenia.
    Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
    Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone palmitate for schizophrenia.
    Nussbaum AM; Stroup TS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD008296. PubMed ID: 22696377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous secretin for autism spectrum disorder.
    Williams KW; Wray JJ; Wheeler DM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003495. PubMed ID: 16034901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P; Stroup S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005237. PubMed ID: 16625629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.